Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SFI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PBK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC127 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TOM1L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C6orf89 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AAK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CNPY3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C14orf159 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LEPROTL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDRG3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRC37A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
DOCK5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C18orf25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC20A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXOC7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCTN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IPO13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPTAN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YPEL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAST2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on